Clinical data | |
---|---|
Pronunciation | /ˌpræzɪˈkwɒntɛl/ |
Trade names | Biltricide |
AHFS/Drugs.com | Monograph |
MedlinePlus | a608048 |
License data |
|
Pregnancy category |
|
Routes of administration | Human use: by mouth (tablets) |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | Relatively small |
Metabolism | Liver |
Elimination half-life | 0.8–1.5 hours (main metabolites: 4–5 hours) |
Excretion | Kidney (mainly) |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.054.126 |
Chemical and physical data | |
Formula | C19H24N2O2 |
Molar mass | 312.413 g·mol−1 |
3D model (JSmol) | |
Melting point | 136 to 138 °C (277 to 280 °F) |
| |
| |
(verify) |
Praziquantel (PZQ), sold under the brandname Biltricide among others, is a medication used to treat a number of types of parasitic worm infections in mammals, birds, amphibians, reptiles, and fish.[3] In humans specifically, it is used to treat schistosomiasis, clonorchiasis, opisthorchiasis, tapeworm infections, cysticercosis, echinococcosis, paragonimiasis, fasciolopsiasis, and fasciolosis.[3] It should not be used for worm infections of the eye.[4] It is taken by mouth.[3]
Side effects in humans may include poor coordination, abdominal pain, vomiting, headache, and allergic reactions.[4] While it may be used during pregnancy, it is not recommended for use during breastfeeding.[4] Praziquantel is in the anthelmintic class of medications.[3] It works partly by affecting the function of the worm's sucker.[3]
Praziquantel was approved for medical use in the United States in 1982.[3] It is on the World Health Organization's List of Essential Medicines.[5]